Combined heart-liver transplantation with extended cardiopulmonary bypass

Singapore Medical Journal

Volumn 52, Issue 3, 2011, Pages

  Marriott, A J ^a   Hwang, N C ^a   Lai, F O ^a   Tan, C K ^b   Tan, Y M ^b   Lim, C H ^b   Boey, S ^a   Tay, S M ^a   Cheow, P C ^b   Lim, Y P ^b   Chan, T ^b   Loh, K ^a   Kwok, B ^b   Chung, A ^b   Sivathasan, C ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Cardiopulmonary bypass; Familial amyloid polyneuropathy; Heart transplantation; Liver transplantation; Reperfusion injury

Indexed keywords

FRESH FROZEN PLASMA; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; TRANEXAMIC ACID;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD CLOTTING DISORDER; CARDIAC GRAFT REJECTION; CARDIOPULMONARY BYPASS; CASE REPORT; DIARRHEA; ELECTROMYOGRAPHY; FAMILIAL AMYLOID POLYNEUROPATHY; GENE MUTATION; HEART AMYLOIDOSIS; HEART CATHETERIZATION; HEART LIVER TRANSPLANTATION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NERVE CONDUCTION; ORTHOSTATIC HYPOTENSION; SENSORIMOTOR NEUROPATHY; SURGICAL TECHNIQUE; TRANSTHORACIC ECHOCARDIOGRAPHY; URINE INCONTINENCE;

AMYLOID NEUROPATHIES, FAMILIAL; CARDIOPULMONARY BYPASS; HEART FAILURE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REPERFUSION; TREATMENT OUTCOME;

EID: 79958257576     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Adams D, Samuel D, Goulon-Goeau C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000; 123:1495-504.
2. Stangou AJ, Hawkins PN, Heaton ND, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998; 66:229-33.
3. Herlenius G, Wilczek HE, Larsson M, Ericzon BG. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 2004; 77:64-71.
4. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-70.
5. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24:1710-20.
6. Pomfret EA, Lewis WD, Jenkins RL, et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998; 65:918-25.
7. Dubrey SW, Davidoff R, Skinner M, et al. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997; 64:74-80.
8. Offstad J, Schrumpf E, Geiran O, Søreide O, Simonsen S. Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia. Clin Transplant 2001; 15:432-6.
9. Diaz GC, Renz JF, Nishanian E, et al. Anesthetic management of combined heart- transplantation. J Cardiothorac Vasc Anesth 2007; 21:253-6.
10. Grezzana TJ, Corso CO, Zanotelli ML, et al. Oxidative stress, hepatocellular integrity, and hepatic function after initial reperfusion in human hepatic transplantation. Transplant Proc 2004; 36:843-5.
11. Weinbroum AA, Hochhauser E, Rudick V, et al. Direct induction of acute lung and myocardial dysfunction by liver ischemia and reperfusion. J Trauma 1997; 43:627-35.
12. Bernier PL, Grenon M, Ergina P, et al. Combined simultaneous heart and liver transplantation with complete cardiopulmonary bypass support. Ann Thorac Surg 2007; 83:1544-5.
13. Groeneveld AB, Jansen EK, Verheij J. Mechanisms of pulmonary dysfunction after on-pump and off-pump cardiac surgery: a prospective cohort study. J Cardiothorac Surg 2007; 2:11.